The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of histology on the efficacy and safety of pembrolizumab (pembro) monotherapy for advanced urothelial carcinoma (UC) in the phase 3 KEYNOTE-045 and KEYNOTE-361 trials.
 
Patrizia Giannatempo
Honoraria - Astellas Pharma; Gilead Sciences; Janssen medical Affairs; Pfizer
Consulting or Advisory Role - Astellas Pharma; Gilead Sciences; Janssen Oncology; Merck; Pfizer
Research Funding - AstraZeneca; Ipsen; MSD Oncology
Travel, Accommodations, Expenses - Bristol-Myers Squibb/Roche; Bristol-Myers Squibb/Roche; Pfizer
 
Jean-Pascal H. Machiels
Consulting or Advisory Role - ALX Oncology; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; CUE Biopharma; eTHERNA; F-star; Incyte; Innate Pharma; ITeos Therapeutics; Janssen; Merck Serono; Merck Sharp & Dohme; NEKTAR; Novartis; Pfizer; Roche
Research Funding - Bayer; Janssen; Novartis; Sanofi
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Gilead Sciences; MSD; Pfizer
Other Relationship - PsiOxus Therapeutics
 
Naoto Sassa
No Relationships to Disclose
 
Jose Angel Arranz Arija
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; EUSA Pharma; Ipsen; Merck; MSD Oncology; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb (Inst)
 
Yasuhisa Fujii
Speakers' Bureau - Merck
Research Funding - Merck/Schering Plough
Travel, Accommodations, Expenses - Merck
 
Wen-Pin Su
No Relationships to Disclose
 
Bhumsuk Keam
Honoraria - Lilly; Merck; Yuhan
Consulting or Advisory Role - CBS Bioscience; Handok; ImmuneOncia; NeoImmuneTech; Trial Informatics
Research Funding - AstraZeneca; MSD Oncology; Ono Pharmaceutical
 
Stephane Culine
Consulting or Advisory Role - Astellas Pharma; Bayer; Bristol-Myers Squibb/Pfizer; Janssen
Speakers' Bureau - AstraZeneca/MedImmune; Janssen; Merck; Takeda
Travel, Accommodations, Expenses - Ipsen; Janssen
 
Ying-Chun Shen
No Relationships to Disclose
 
José Muñoz-Langa
Speakers' Bureau - AstraZeneca; LEO Pharma
 
David Leonid Sarid
Consulting or Advisory Role - MSD
Travel, Accommodations, Expenses - MSD
 
Maureen J.B. Aarts
Consulting or Advisory Role - Amgen; Astellas Pharma; Bayer; Bristol-Myers Squibb; Merck; MSD/Merck; Novartis; Pierre Fabre; Sanofi
Research Funding - Merck
 
Fabio Calabro
No Relationships to Disclose
 
Eli Rosenbaum
Stock and Other Ownership Interests - Brainsway; Conergent
Consulting or Advisory Role - Astellas Pharma; Bayer; Janssen; MSD Oncology; Teva
Speakers' Bureau - MSD Oncology
 
Olesya Goldman
No Relationships to Disclose
 
Blanca Homet Moreno
Employment - Merck Sharp & Dohme
Stock and Other Ownership Interests - Merck Sharp & Dohme
 
Abhishek Amar Bavle
Employment - Merck
Leadership - Merck
Stock and Other Ownership Interests - Merck
Honoraria - Merck
Research Funding - Merck
Travel, Accommodations, Expenses - Merck
 
Jin Zhi Xu
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Sun Young Rha
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Daiichi Sankyo; Eisai; Eutilex; indivumed; LG Chem; MSD Oncology; Ono Pharmaceutical
Speakers' Bureau - Amgen; AstraZeneca; BMS/Ono; Daiichi Sankyo/UCB Japan; Eisai; Lilly; MSD Oncology
Research Funding - Amgen (Inst); ASLAN Pharmaceuticals; Astellas Pharma; AstraZeneca; Bayer; BeiGene; Bristol-Myers Squibb; Daichii Sankyo; Eisai; Indivumed; Lilly; MSD Oncology; Roche/Genentech; Sillajen; Zymeworks